Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2Phase 2 2Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 1Prostate Adenocarcinoma 1

Interventions

pembrolizumab 64Carboplatin 63Paclitaxel 54Magnetic Resonance Spectroscopy 45Specimen Handling 43Cisplatin 43Gemcitabine 35Bevacizumab 31Docetaxel 30Doxorubicin 29Leucovorin 28Fluorouracil 27Dexamethasone 27Cyclophosphamide 26Pemetrexed 25Radiation 23Oxaliplatin 23Radiotherapy 22Etoposide 22durvalumab 21Nivolumab 21Letrozole 21Vincristine 20Rituximab 20Irinotecan 20Taxes 19Prednisone 19Capecitabine 19Lenalidomide 18130-nm albumin-bound paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Radiation Dose Hypofractionation × 30 days × Clear all
NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

NRG Oncology

Phase 3 Completed
296 enrolled 29 charts
Genitourinary

Prostate Adenocarcinoma

NCT03987386 2026-05-20

Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
186 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡